The leading authoritative journal since 1982 devoted to the evolving body of law and government regulation concerning biotechnology, particularly in the industries in which new products from these technologies are developing the most rapidly: pharmaceuticals, chemicals, agriculture, food processing, energy, mineral recovery, and waste treatment. All legal aspects are rapidly reported, and critical and often hard-to-obtain documents are reproduced.

The Biotechnology Law Report has been the leading authoritative journal since 1982, dedicated to the evolving body of law and government regulation concerning biotechnology. It particularly focuses on industries where new products from these technologies are developing rapidly, including pharmaceuticals, chemicals, agriculture, food processing, energy, mineral recovery, and waste treatment. All legal aspects are reported promptly, and critical documents that are often hard to obtain are reproduced.

《Biotechnology Law Report》是自1982年以来的权威期刊，专注于与生物技术相关的法律和政府法规的发展，特别是在制药、化学、农业、食品加工、能源、矿物回收和废物处理等行业中，这些行业的新产品正在快速发展。期刊迅速报道所有法律方面的内容，并重现关键且通常难以获得的文件。

Biotechnology Law Report

CHRISTOPHER M. HOLMAN

The Evolving Grace Period for U.S. Patent Applicants

美国专利申请人宽限期的演变

Christopher M. Holman

A Review of Judicial Opinions Interpreting the Novelty Provisions of the America Invents Act

《美国发明法案新颖性条款解释的司法意见综述》

Today, the term "HIPAA" is widely used and misunderstood by many even though personal privacy is a hot topic in society. Technology is beginning to allow people significantly more access to their own and others' personal information. Though the Heath Insurance Portability and Accountability Act (HIPAA) is still serving the purpose for which it was originally designed, many people believe that the protection it provides is simply not enough for this day and age. Before diving into HIPAA and its flaws, it is important to fully establish what HIPAA is and does to protect our information. Instead of finding the problems with HIPAA regulations, this article examines some ways that HIPAA could be strengthened through amendments to itself or by adding another layer of federal privacy regulation in addition to HIPAA. This article looks toward the European Union's General Data Protection Regulation (GDPR), one of the world's tightest privacy regulations, to find specific ways that HIPAA could be molded into a more stringent regulation of an individual's privacy and sensitive information. Specifics such as introducing the right to erasure and applying these regulations to any entity that encounters or processes an individual's information are just the beginning of supplementing HIPAA and U.S. privacy laws so that most of the population can both understand and be comfortable with how their information is collected and used by others in this technology-driven world.

Ashtyn Oakley

HIPAA, HIPPA, or HIPPO: What Really Is the Heath Insurance Portability and Accountability Act?

HIPAA、HIPPA还是HIPPO：究竟什么是《健康保险可携性与责任法案》？

Astellas Pharma, Inc. v. Sandoz Inc. USA, Inc

安斯泰来制药公司诉山德士公司美国分公司

Allergan USA, Inc. v. MSN Lab’ys Priv. Ltd

艾尔建美国公司诉MSN实验室私人有限公司案

Huaiyin Zhang

Yuqi Ji

The Redemption of Drug Patent Linkage System: The Dilemma and Improvement in the Qualification System of Market Exclusivity Period for China’s First Generic Drug

药品专利链接制度救赎：我国首仿药市场独占期资格制度的困境与完善

Steven J. Zweig

Selected Developments in Biotechnology Law and the Biotechnology Industry

生物技术法与生物技术产业中的重要进展

Abbreviation	Biotechnol. Law Rep.
Journal Impact	0.40
Quartiles(Global)	BIOTECHNOLOGY & APPLIED MICROBIOLOGY(Q4)

ISSN	0730-031X, 1557-8704
h-index	10

Publication Information	Publisher: Mary Ann Liebert Inc.，Publishing cycle: Bimonthly，Journal Type: journal，Open Access Journals: No
Basic data	Year of publication: 1999，Proportion of original research papers: 100.00%，Self Citation Rate:50.00%， Gold OA Rate: 0.00%
Average review cycle	网友分享经验：>12周，或约稿
Average recruitment ratio	网友分享经验：容易

Biotechnology Law Report

Journal Citation Format

A journal article with 1 author

A journal article with 2 authors

A journal article with 3 authors

A journal article with 5 or more authors

Books Citation Format

Thesis Citation Format

Web sites Citation Format

Patent Citation Format

Staying up late manually editing references? ivySCI automatically matches journals and helps you generate references with a single click.

Share Submission Experience

The Evolving Grace Period for U.S. Patent Applicants

A Review of Judicial Opinions Interpreting the Novelty Provisions of the America Invents Act

HIPAA, HIPPA, or HIPPO: What Really Is the Heath Insurance Portability and Accountability Act?

Astellas Pharma, Inc. v. Sandoz Inc. USA, Inc

Allergan USA, Inc. v. MSN Lab’ys Priv. Ltd

Allergan USA, Inc. v. MSN Lab’ys Priv. Ltd

The Redemption of Drug Patent Linkage System: The Dilemma and Improvement in the Qualification System of Market Exclusivity Period for China’s First Generic Drug

Astellas Pharma, Inc. v. Sandoz Inc. USA, Inc

The Evolving Grace Period for U.S. Patent Applicants

Selected Developments in Biotechnology Law and the Biotechnology Industry